Wellstat Therapeutics Corporation operates as a biopharmaceutical company. The Company researches, develops, and commercializes new treatments in the fields
Wellstat Therapeutics Corporation – Product Pipeline Review – 2024. Summary Global Markets Direct's pharmaceuticals report, Wellstat Therapeutics
Corporate Family; Similar Companies; Credit Reports. Wellstat Diagnostics, LLC Wellstat Therapeutics. Company Description: Key Principal: Samuel J
Wellstat Therapeutics Corporation and Wellstat Biologics Corporation Bankruptcy (0:23-bk- ), Maryland Bankruptcy Court, Filed: - PacerMonitor Mobile Federal and Bankruptcy Court PACER Dockets
References. Wellstat Therapeutics Corporation (2024). Vistogard (uridine triacetate) US Package Insert. Wellstat Therapeutics Corporation (2024).
Wellstat Therapeutics Corporation Wellstat Biologics Corporation Hyperion Catalysis International Corporation Proteinix, Inc. Integrated Chemical
Who acquired Wellstat Therapeutics Corporation (rights to uridine triacetate)?. Wellstat Therapeutics Corporation (rights to uridine triacetate) was acquired by
Wellstat Therapeutics Corporation is located at Shady Grove Rd Suite A600 in Rockville, Maryland . Wellstat Therapeutics Corporation can be contacted
Wohlstadter, Hyperion Catalysis International, Wellstat Vaccines, LLC, Wellstat ImmunoTherapeutics Corporation, Wellstat Management
Comments